Aveanna Healthcare (NASDAQ:AVAH) Hits New 1-Year High – Time to Buy?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) reached a new 52-week high during trading on Tuesday . The stock traded as high as $10.28 and last traded at $10.27, with a volume of 958512 shares traded. The stock had previously closed at $9.86.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Aveanna Healthcare in a research note on Wednesday, October 8th. Truist Financial decreased their price objective on Aveanna Healthcare from $6.00 to $5.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Raymond James Financial raised Aveanna Healthcare from a “market perform” rating to an “outperform” rating and set a $9.00 price objective on the stock in a research note on Monday, August 11th. Finally, Wall Street Zen raised Aveanna Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 9th. Three research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $8.08.

Aveanna Healthcare Price Performance

The firm has a 50-day moving average of $8.41 and a 200-day moving average of $6.09. The stock has a market cap of $1.98 billion, a PE ratio of 118.50 and a beta of 2.05.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Monday, May 22nd. The company reported $0.04 earnings per share (EPS) for the quarter. Aveanna Healthcare had a negative return on equity of 54.56% and a net margin of 0.85%.The firm had revenue of $450.53 million during the quarter. Equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors have recently added to or reduced their stakes in the company. Rhumbline Advisers grew its holdings in Aveanna Healthcare by 4.0% during the 1st quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock valued at $410,000 after buying an additional 2,918 shares in the last quarter. MetLife Investment Management LLC grew its holdings in Aveanna Healthcare by 16.2% during the 1st quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock valued at $169,000 after buying an additional 4,349 shares in the last quarter. AQR Capital Management LLC grew its holdings in Aveanna Healthcare by 21.2% during the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after buying an additional 4,602 shares in the last quarter. Bank of New York Mellon Corp grew its holdings in Aveanna Healthcare by 4.2% during the 1st quarter. Bank of New York Mellon Corp now owns 114,881 shares of the company’s stock valued at $623,000 after buying an additional 4,655 shares in the last quarter. Finally, Invesco Ltd. grew its holdings in Aveanna Healthcare by 31.1% during the 2nd quarter. Invesco Ltd. now owns 20,006 shares of the company’s stock valued at $105,000 after buying an additional 4,742 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.